Daniel Muth
Overview
Explore the profile of Daniel Muth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bajka A, Foa N, Sidhu S, Rejdak M, Said S, Wiest M, et al.
Klin Monbl Augenheilkd
. 2023 Jul;
240(4):e1.
PMID: 37451287
No abstract available.
2.
Bajka A, Foa N, Sidhu S, Rejdak M, Said S, Wiest M, et al.
Klin Monbl Augenheilkd
. 2023 May;
240(4):608-612.
PMID: 37164413
Purpose: To assess optic nerve head (ONH) and macular blood flow in young healthy volunteers using laser speckle flowgraphy (LSFG). Methods: This is a prospective single-center study conducted at the...
3.
Schuh A, Muth D, Shajari M, Mayer W, Priglinger S, Messmer E
Klin Monbl Augenheilkd
. 2021 Feb;
238(8):893-898.
PMID: 33540463
Purpose: To evaluate the effect of IPL (intense pulsed light) treatment in patients with meibomian gland dysfunction (MGD). Methods: Clinical data of 25 patients with MGD who underwent IPL treatment...
4.
Reznicek L, Muth D, Vogel M, Hirneiss C
Curr Eye Res
. 2016 Jul;
42(3):418-423.
PMID: 27419859
Purpose: To evaluate the relationship between functional parameters of repeated flicker-defined form perimetry (FDF) and structural parameters of spectral-domain optical coherence tomography (SD-OCT) in glaucoma suspects with normal findings in...
5.
Reznicek L, Muth D, Kampik A, Neubauer A, Hirneiss C
Br J Ophthalmol
. 2013 Aug;
97(11):1410-4.
PMID: 23969314
Background: To evaluate the agreement of intraocular pressure (IOP) and central corneal thickness (CCT) measurements obtained with the non-contact tonometer Corvis Scheimpflug Technology (Corvis ST, OCULUS, Wetzlar, Germany) versus Goldmann...
6.
Dreidax D, Gogolin S, Schroeder C, Muth D, Brueckner L, Hess E, et al.
Hum Mol Genet
. 2013 Jan;
22(9):1735-45.
PMID: 23343716
The TP53 tumor suppressor pathway is abrogated by TP53 mutations in the majority of human cancers. Increased levels of wild-type TP53 in aggressive neuroblastomas appear paradox but are tolerated by...
7.
Henrich K, Bauer T, Schulte J, Ehemann V, Deubzer H, Gogolin S, et al.
Cancer Res
. 2011 Mar;
71(8):3142-51.
PMID: 21385898
A distal portion of human chromosome 1p is often deleted in neuroblastomas and other cancers and it is generally assumed that this region harbors one or more tumor suppressor genes....
8.
Muth D, Ghazaryan S, Eckerle I, Beckett E, Pohler C, Batzler J, et al.
Cancer Res
. 2010 Apr;
70(9):3791-802.
PMID: 20424123
The cell cycle regulator, SKP2, is overexpressed in various cancers and plays a key role in p27 degradation, which is involved in tumor cell dedifferentiation. Little is known about the...
9.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al.
Nat Cell Biol
. 2010 Feb;
12(3):247-56.
PMID: 20173740
MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly targets CDH1, the E-cadherin-encoding messenger...
10.
Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al.
Genome Biol
. 2009 Jun;
10(6):R64.
PMID: 19531210
Gene expression analysis of microRNA molecules is becoming increasingly important. In this study we assess the use of the mean expression value of all expressed microRNAs in a given sample...